$LII

Somasundaram Sivasankaran sold (to issuer) 343 shares of LII

Somasundaram Sivasankaran sold (to issuer) 343 shares of LENNOX INTERNATIONAL INC (LII) on 2026-05-26.

Original reporting
SEC EDGAR · Somasundaram Sivasankaran
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LII
Neutral
low confidence
Mentioned
$LII
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIINeutralLow
01

Why it matters

A director sold 343 shares to the issuer; the filing does not include price or total value and does not cite any company-specific event or guidance change.

02

Market read

This provides incremental positioning information from an insider but lacks fundamental details to justify a high-conviction trading decision.

03

What to watch

No sale price is disclosed and there is no 10b5-1 plan; traders may over-interpret the absence of a plan without knowing the company’s specific mechanics for “sale to issuer” transactions.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-05-28 for a 2026-05-26 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Lennox International Inc.

Company-level read

Ticker impact

$LIINeutralLow confidence
Context

Lennox International director Somasundaram Sivasankaran sold 343 shares to the issuer, per a newly filed SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless follow-on filings show sustained selling.

Evidence & confidence

The filing discloses an insider transaction but provides no sale price, no change in business outlook, and no stated reason; insider sales are common and often not predictive.

Market effects

No clear sector read-through from a single director sale to the issuer.

None indicated.

None indicated.

Counterpoint

The sale could be administrative (e.g., issuer buyback participation or liquidity need) and not a bearish signal, especially since the transaction is to the issuer.

Key entities

  • Lennox International Inc

    US-listed company whose director insider sale is disclosed on Form 4.

  • Somasundaram Sivasankaran

    Director who sold 343 shares to the issuer on 2026-05-26.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMGNMed

As Fed hike looms, AI strategy’s mid-cap picks draw attention with 580% gain

U.S. 10-year Treasury yields hit 5%, highest since 2007, ahead of Fed decision with 90% chance of a 25-basis-point hike. Investing.com's Mid-Cap Movers strategy gained 580.7% since 2013, outperforming S&P MidCap 400. Top performers include Commvault (CVLT, +8.5%), Insight Enterprises (NSIT, +5.0%), and Wingstop (WING, +4.7%). Lennox International (LII) downgraded to Hold, Amgen (AMGN) FDA approval for Imdelltra.

$AAONMed

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

$LIIMed

Lennox (LII) Q2 2026 Earnings Call Transcript

Lennox (LII) Q2 2026 call said residential demand remains challenging, with revenue down 7% YoY due to a 12% unit-volume decline, partially offset by mix and pricing (+3%) and acquisitions (+2%). Building Climate Solutions revenue rose 24% (organic +12%). Management cut earnings outlook and expects recovery benefits into 2027; it reported 92% TTM free-cash conversion and repurchased about $130M shares.

$LIIMed

Lennox Residential HVAC Sales Fall 7% in Second Quarter

Lennox CEO Alok Maskara said Q2 residential HVAC demand was constrained by elevated mortgage rates, inflation, low consumer confidence, affordability pressures, and weather variability. Lennox expects recovery to extend into 2027. Residential new construction revenues fell about 30% as the firm exited low-margin RNC. Replacement held up, pricing added 3%, and full-year revenue growth guidance remains ~8%.

$LIIMedAI 8/10

Why Lennox Stock Crashed Today

Lennox International (NYSE: LII) shares fell about 19.9% after Q2 results. The company reported EPS of $7.72 vs. $7.61 expected, but revenue missed at about $1.5B vs. nearly $1.6B. Lennox cited continued softness in residential HVAC demand, with residential volumes down 7%. It lowered its 2026 EPS outlook to $23-$24 vs. $24.52 expected.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.